Association of Two Indices of Insulin Resistance Marker with Abnormal Liver Function Tests: A Cross-Sectional Population Study in Taiwanese Adults

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2021-12, Vol.58 (1), p.4
• Main Authors: Kurniawan, Adi-Lukas, Hsu, Chien-Yeh, Chao, Jane C-J, Paramastri, Rathi, Lee, Hsiu-An, Jallow, Amadou-Wurry
• Format: Article
• Language: English
• Subjects: Alanine Transaminase; Biomarkers; Body mass index; Cardiovascular disease; Cholesterol; Clinical medicine; Cross-Sectional Studies; Diabetes; Epidemiology; Female; Food; Glucose; High density lipoprotein; Humans; Insulin Resistance; Kidney diseases; Laboratories; Lipoproteins; Liver Diseases; liver function; Male; Medical screening; Metabolic syndrome; Phosphatase; Questionnaires; Sleep; Taiwan; triglyceride-glucose index; Triglycerides; triglycerides to high-density lipoprotein cholesterol ratio; Uric acid; Womens health
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina58010004

Insulin resistance (IR) is frequently associated with chronic low-grade inflammation and has an important role as a mediator in the development of liver disease. Thus, this study aimed to explore the relationship between two indexes of IR and abnormal liver function parameters. This cross-sectional study obtained data of 41,510 men and 92,357 women aged ≥30 years from a private health screening institute in Taiwan. Two IR indexes namely triglyceride-glucose (TyG) index and triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio were used to examine their relationship to predict abnormal liver function parameters (aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), and alkaline phosphatase (ALP)). Positive trend was shown for the association of TyG index in the highest quintile (Q5) and risk of high AST (OR = 1.45, 95% CI: 1.33-1.57), high ALT (OR = 1.85, 95% CI: 1.73-1.97), high GGT (OR = 2.04, 95% CI: 1.93-2.15), and high ALP (OR = 1.13, 95% CI: 1.07-1.19) compared with the median quintile (Q3) in the fully adjusted model. Similarly, participants in the Q5 of the TG/HDL-C ratio were associated with 1.38 (95% CI: 1.27-1.49), 1.71 (95% CI: 1.61-1.82), 1.75 (95% CI: 1.66-1.84), and 1.21 (1.16-1.27) odds for having high AST, ALT, GGT, and ALP respectively. The AUC (95% CI) value of the TyG index for predicting high AST, high ALT, and high GGT was 0.699 (0.692-0.705), 0.738 (0.734-0.742), and 0.752 (0.749-0.755), respectively. Meanwhile, the AUC (95% CI) of the TG/HDL-C ratio for predicting high AST, high ALT, and high GGT was 0.680 (0.673-0.686), 0.738 (0.734-0.742), 0.734 (0.731-0.738), respectively. Our study supported that the TyG index and TG/HDL-C ratio may be useful as non-invasive methods to predict the existence of impaired liver function in the early stage.